SCHEMBL5118340

SCHEMBL5118340

CCOC(=O)c1cnc(-c2ccc(Cl)c(C)c2)nc1Oc1ccccc1Cl

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.64
POLB P06746 2/20 0.59
CYP2C9 P11712 2/20 0.59
CYP2C19 P33261 2/20 0.59
L3MBTL1 Q9Y468 1/20 0.59
ALDH1A1 P00352 9/20 0.55
LMNA P02545 3/20 0.55
MAPT P10636 8/20 0.54
HTT P42858 1/20 0.54
NPSR1 Q6W5P4 3/20 0.53
SMN1; SMN2 Q16637 3/20 0.49
MAPK1 P28482 1/20 0.49
ATM Q13315 1/20 0.49
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
TP53 P04637 1/20 0.48
KDM4E B2RXH2 1/20 0.46
KMT2A Q03164 2/20 0.45
HPGD P15428 1/20 0.45
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5115578 0.94 CYP1A2 (0.62) CYP1A2POLBCYP2C9CYP2C19L3MBTL1
SCHEMBL5115669 0.89 CYP1A2 (0.59) CYP1A2POLBCYP2C9CYP2C19L3MBTL1
SCHEMBL5111739 0.88 CYP1A2 (0.75) CYP1A2POLBCYP2C9CYP2C19L3MBTL1
SCHEMBL5118105 0.88 CYP1A2 (0.60) CYP1A2POLBCYP2C9CYP2C19L3MBTL1
SCHEMBL5110692 0.87 TDP1 (0.54) CYP1A2POLBCYP2C9CYP2C19L3MBTL1
SCHEMBL5120276 0.87 CYP1A2 (0.56) CYP1A2POLBCYP2C9CYP2C19L3MBTL1
SCHEMBL5110787 0.85 CYP1A2 (0.57) CYP1A2POLBCYP2C9CYP2C19L3MBTL1
SCHEMBL5118274 0.85 CYP1A2 (0.61) CYP1A2POLBCYP2C9CYP2C19L3MBTL1
SCHEMBL5289551 0.85 MAPT (0.48) CYP1A2POLBCYP2C9CYP2C19L3MBTL1
SCHEMBL5124912 0.84 CYP1A2 (0.55) CYP1A2POLBCYP2C9CYP2C19L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080194598-A1 Pyrimidine Carboxylic Acid Derivatives and Use Thereof BAYER HEALTHCARE AG (DE) 2008-08-14 US disclosed
US-20080194598-A1 Pyrimidine Carboxylic Acid Derivatives and Use Thereof BAYER HEALTHCARE AG (DE) 2008-08-14 US disclosed
US-20080194598-A1 Pyrimidine Carboxylic Acid Derivatives and Use Thereof BAYER HEALTHCARE AG (DE) 2008-08-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194598-A1 Pyrimidine Carboxylic Acid Derivatives and Use Thereof DPYD, TYMP, TYMS CYP1A2 933/4885POLB 244/4885CYP2C9 388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.